Monovalent chimpanzee adenoviral vectored Sudan Ebolavirus vaccine

Chimpanzee adenovirus vector-based Sudan ebolavirus vaccine · Albert B. Sabin Vaccine Institute

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Monovalent chimpanzee adenoviral vectored Sudan Ebolavirus vaccine, covering 2026-02-10 to 2026-03-04. Get the full timeline:

Most recent: Clinical Trial Update: Monovalent Chimpanzee Adenoviral-Vectored Sudan Ebolavirus Vaccine in Healthy Adults [Phase 2]

See pricing